Ongoing projects and patient cohorts
Mucosal measurements to target Mucosal therapies:
1. Right strategy, right population
Respiratory infections affect children worldwide, but their epidemiology, risk factors and healthcare context differ between populations and settings. Prevention and treatment strategies therefore cannot simply be transferred from one population to another.
We study respiratory infections across diverse global settings to identify which strategies work, for whom, and under which circumstances, with the aim of developing locally appropriate approaches for vulnerable children.
2. Respiratory samples as biosensor
Respiratory samples such as saliva provide a child-friendly window into what is happening at the site of infection. By measuring pathogens, proteins, antibodies and immune cells, we use these samples as biosensors of both infection and the mucosal immune response.
Our goal is to translate this information into better diagnosis, prediction of disease course and treatment decisions, ultimately bringing respiratory sampling into clinical practice.
3. Understanding mucosal immunity
The respiratory mucosa is our first line of defence against the pathogens we encounter every day. We study how antibodies, immune cells and the respiratory epithelium work together to protect children against respiratory infections, and why this protection sometimes fails. By combining mechanistic, translational and clinical research, we aim to turn this understanding into new strategies that strengthen mucosal protection for prevention and treatment of respiratory infections.
























